Cgw. Dahlberg et al., DIFFERENTIAL EFFECT OF 3 COMMERCIAL HEPARINS ON NA+ H+ EXCHANGE AND GROWTH OF PASMC/, American journal of physiology. Lung cellular and molecular physiology, 14(2), 1996, pp. 260-265
Heparin preparations vary in chemical content and in antiproliferative
activity for pulmonary artery smooth muscle cells (PASMC). Intracellu
lar alkalinization via stimulation of the Na+/H+ antiporter appears to
be a permissive event for proliferation of PASMC. We wondered whether
the variable effect of heparin preparations on PASMC growth might be
due to different degrees of inhibition of the Na+/H+ antiporter and wh
ether variations in chemical formulation might correlate with the inhi
bition. Fluorescent microscopy of bovine PASMC was done using a dye wi
th which fluorescence varies directly with intracellular pH (pH(i)). B
ovine PASMC were preincubated with three heparin preparations previous
ly shown to vary in antiproliferative activity at 1.0 mu g/ml for 24 h
. Platelet-derived growth factor (PDGF; 60 ng/ml) on PASMC without hep
arin resulted in a rise in pH(i) of 0.27 +/- 0.02 pH units. The rise i
n pH units in heparin-treated PASMC was 0.34 +/- 0.03 with Choay, 0.21
+/- 0.02 with Elkins-Sinn, and 0.07 +/- 0.02 with Upjohn (+/- SE; all
P < 0.05; n = 5). Upjohn heparin incubation for as little as 15 min s
till impeded the rise in pH induced by PDGF. Heparin did not block the
Na+/H+ exchanger directly, as it still restored pH(i) in response to
an acid load. Compared with PASMC proliferation induced by 60 ng/ml PD
GF, 1 mu g/ml of Choay, Elkins-Sinn, and Upjohn heparin produced -4 +/
- 7.4, 1.4 +/- 4.8, and 48 +/- 2.2% inhibition of PDGF control, respec
tively (P < 0.05 for Upjohn compared with PDGF and Choay). The heparin
s varied in protein content and amino acid composition. However, amino
acid and glucosamine composition total sulfation, and extent of 3-O-s
ulfation did not predict their activity. Thus inhibition of PDGF activ
ation of the Na+/H+ antiporter by a given heparin preparation correlat
ed well with its ability to inhibit PASMC proliferation.